RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
abnormally increased pressure in the portal venous system, frequently seen in cirrhosis of the liver and other conditions causing obstruction of the portal vein.
View Complete Description-
Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Authors: Juan G Abraldes, Agustin Albillos, Rafael Bañares, Juan Turnes, Rosario González, Juan Carlos García-Pagán, Jaime Bosch
Gastroenterology 2009 May -
Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.
Authors: Marlene Dominguez, Rosa Miquel, Jordi Colmenero, Montserrat Moreno, Joan-Carles García-Pagán, Jaime Bosch, Vicente Arroyo, Pere Ginès, Juan Caballería, Ramón Bataller
Gastroenterology 2009 May
Thought leaders and organizations working on research involving portal hypertension.
- Jaime Bosch
- Juan G Abraldes
- Juan Carlos Garcia-Pagan
- Annalisa Berzigotti
- Juan Carlos García-Pagán
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDD…
- Bayside Health
- Hvidovre University Hospital
- Aga Khan University
- University of Barcelona
- Hospital Clínic
- Institut d'Investigacions Biomèdiques August Pi i Sunyer
- Duke University Medical Center
- University of Texas Southwestern Medical Center
-
Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis
conditions: Portal Hypertension
interventions: none
-
Vasoactive Peptides in Portal Pressure
conditions: Portal Hypertension
interventions: Norfloxacin
Community
-
No NextBio users were found for “portal hypertension”.
Complete your user profile with your interests, if you want others to find you within the NextBio community.
-
No NextBio groups were found for “portal hypertension”.
Be the first to start a group and share your interests with others within the NextBio community.
